Clinical Trial Update: Safety Study of a Helper Peptide Vaccine Plus Adjuvant Combinations for the Treatment of Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A safety study of a helper peptide vaccine plus adjuvant combinations for melanoma was conducted in Phase 1/2 and terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Craig L Slingluff, Jr | Conditions: Melanoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-04-29